Want to join the conversation?
$VAR's backlog at the end of FY15 was $3.5Bil, including approx. $345MM in Varian Particle Therapy backlog, of which the company expects to recognize approx. 50-55% as revenues in FY16. Oncology Systems backlog made up 82% of the total backlog at the end of FY15.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.